Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy

Medulloblastoma (MB) is the most common solid tumour in children and, despite current treatment with a rather aggressive combination therapy, accounts for 10% of all deaths associated with paediatric cancer. Breaking the tumour cells’ intrinsic resistance to therapy-induced cell death should lead to...

Descripción completa

Detalles Bibliográficos
Autores principales: Westhoff, Mike-Andrew, Schuler-Ortoli, Marie, Zerrinius, Daniela, Hadzalic, Amina, Schuster, Andrea, Strobel, Hannah, Scheuerle, Angelika, Wong, Tiana, Wirtz, Christian Rainer, Debatin, Klaus-Michael, Peraud, Aurelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779796/
https://www.ncbi.nlm.nih.gov/pubmed/35056150
http://dx.doi.org/10.3390/ph15010091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779796/
https://www.ncbi.nlm.nih.gov/pubmed/35056150
http://dx.doi.org/10.3390/ph15010091

Ejemplares similares